---
title: "Lakewood-Amedex (LABT.US) Surges 25% Intraday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284912994.md"
description: "Lakewood-Amedex 生物治疗公司（LABT.US）现价 $3.340，当日 +25.56%，盘中短线涨幅显著，市值 0.00 亿。公司专注于生物治疗领域，盘中异动或与董事会新成员 Joseph Tucker 博士加入有关。近期公司频繁出现股价波动，暂无其他公开催化剂消息。"
datetime: "2026-05-01T15:01:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284912994.md)
  - [en](https://longbridge.com/en/news/284912994.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284912994.md)
---

# Lakewood-Amedex (LABT.US) Surges 25% Intraday

Lakewood-Amedex Biotherapeutics (LABT.US) is trading at $3.340, up **+25.56%** intraday, showing significant short-term price movement. Market cap stands at $0.00 billion.

The company focuses on biotherapeutics. The surge may be linked to the appointment of Dr. Joseph Tucker to the board. No other major catalysts have been disclosed recently, though notable volatility persists.

### Related Stocks

- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)

## Related News & Research

- [Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress | ATRA Stock News](https://longbridge.com/en/news/286148673.md)
- [13:19 ETHyosung TNC Marks a Major Step in its Integrated Bio-Spandex Platform at Global Fashion Summit 2026](https://longbridge.com/en/news/286296991.md)
- [Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement](https://longbridge.com/en/news/286834766.md)
- [Alaunos Reports Preclinical Aln1003 Data Showing Effects On Insulin-Resistance-Related Biomarkers And Liver Histology In Diet-Induced Obesity Models](https://longbridge.com/en/news/286776760.md)
- [AMETEK, Inc. $AME Stock Holdings Trimmed by Bank Julius Baer & Co. Ltd Zurich](https://longbridge.com/en/news/286381855.md)